Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization.

Yoshihiro Sakamoto(Kyorin University), Tomoo Kosuge(Tokyo National Hospital), Takahiro Kajiwara, Satoshi Nara, Kazuaki Shimada(National Cancer Center Hospital East), Minoru Esaki, Tsuyoshi Sano(Aichi Medical University), Yasuaki Arai(Tokyo National Hospital), Junji Yamamoto(National Defense Medical College)
PubMed
July 22, 2010
Cited by 12

Related Papers

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial
|Gut|2019|732
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
|Japanese Journal of Clinical Oncology|2018|534
CT-guided needle biopsy of lung lesions: A survey of severe complication based on 9783 biopsies in Japan
|European Journal of Radiology|2006|499
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472